4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-22-000020
Chief Commercial Officer gave up 742 shares (to pay taxes)
- Chief Commercial Officer acquired 2,542 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Poddar Richa · Chief Commercial Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-18 | Exercise or conversion : show line 1 in the form | +1,884 | 4,525 | D | ||
| 2022-02-22 | Exercise or conversion : show line 2 in the form | +658 | 5,183 | D | ||
| 2022-02-22 | Shares withheld for taxes : show line 3 in the form | −742 | $29.08 | $21,577 | 4,441 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-18 | Exercise or conversion : show line 4 in the form Performance share units | −1,884 | 1,883 | D |
| 2022-02-22 | Exercise or conversion : show line 5 in the form Restricted stock units | −658 | 0 | D |
Loading xslF345X03/wf-form4_164565067739124.xml…